Skip to content
Chr. Hansen & FMC Corporation announce global strategic alliance for biological solutions for plant protection

Press release -

Chr. Hansen & FMC Corporation announce global strategic alliance for biological solutions for plant protection

In line with its recently announced “Nature’s No. 1” strategy Chr. Hansen enters the rapidly growing biological plant protection market through an exclusive global strategic alliance with FMC covering development and commercialization of biological crop protection products.
The global agriculture sector is facing a massive productivity challenge in the years ahead, and biological solutions will become an ever more important way to address this challenge. We are excited about this new alliance, which accelerates our entry in the plant protection market by combining Chr. Hansen’s unique technology platform for bacterial solutions with FMC’s strong route to market and application know-how”, says Christian Barker, Executive Vice President, Health & Nutrition Division, Chr. Hansen Holding A/S.



No one knows microbiology and fermentation better than the team at Chr. Hansen. Their expertise in scouting, screening and scale-up production complements the work we do so well in formulation and bringing products to market. We look forward to working with Chr. Hansen to create a broad portfolio of biological solutions
says Mark A. Douglas, president, FMC Agricultural Solutions.



The new strategic alliance creates a powerful foundation for FMC and Chr. Hansen to compete in the multi-billion dollar biological crop protection market. Under the arrangement, Chr. Hansen will provide scouting, screening, scale up and fermentation manufacturing expertise while FMC will provide scouting, screening, formulation capabilities, product development and registration experience as well as global market access. The two companies will develop new products, knowledge and biological expertise within the collaboration’s framework.



The new alliance builds on an existing collaboration between the two companies, under which a Brazilian launch of the Sugarcane Nemix C product will be made in late 2013, targeting the biggest sugarcane market in the world of 9 million hectares. Nemix C increases growth and yield through enhanced root development and protection and is a purely biological product. Going forward, the alliance will expand into additional geographies and crop types with existing and new products.



FMC Corporation is a diversified chemical company serving agricultural, industrial, environmental, and consumer markets globally for more than a century with innovative solutions, applications and quality products. In 2012, FMC had annual sales of approximately USD 3.7 billion. The company employs approximately 6,000 people throughout the world, and operates its businesses in four segments: FMC Agricultural Solutions, FMC Health and Nutrition, FMC Minerals, and FMC Peroxygens. For more information, visit www.FMC.com.



As stated in company announcement no. 22, 3 September 2013 the five-year financial ambition for the Health & Nutrition Division is an average annual organic growth rate above 10% from the core business. Plant protection is expected to add additional growth towards the end of the period.



For further information, please contact:



Christian Barker, EVP Health & Nutrition
Tel: +45 4574 7474



Anders Mohr Christensen, Senior Director IR
Tel: +45 4574 7618



Kristine Ahrensbach, Director Corporate Communications
Tel: +45 4574 7623

Topics


Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark